Sort
40,608 grants matching “prostate cancer”
POTENTIATING TUMOR IMMUNITY IN THE MURINE TRAMP MODEL FOR PROSTATE CANCER USING APTAMER-TARGETED RNAI TO RENDER CDS T CELLS RESISTANT TO TGFBETA INHI
$575,588University Of Miami · · FY2014 · Department of the Army
A new technique to make 68Ga-labeled pharmaceuticals widely available for clinical use
$575,548Joseph Reginald Osborne · Weill Medical Coll Of Cornell Univ · R01 · FY2018 · CA
Translational Pathology Core
$575,479Sue Ellen Martin · University Of Southern California · P30 · FY2022 · CA
H. LEE MOFFITT CANCER CENTER CCOP RESEARCH BASE
$575,473University Of South Florida · U10 · FY2000 · CA
Improving prostate cancer screening by integration of SNPs with blood biomarkers
$575,419Robert J. Klein · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Elucidation of the mechanisms by which cells recognize and respond to different levels of androgens
$575,405Donald P McDonnell · Duke University · R01 · FY2024 · CA
PET-determined prostate brachytherapy dosing using intraoperative image-guidance
$575,384Daniel Song · Johns Hopkins University · R01 · FY2019 · CA
Data Science Core
$575,358Ming Li · University Of Southern California · P30 · FY2025 · CA
Novel radioimmunoconjugates for targeted alpha-particle therapy of metastatic prostatic cancer
$575,279Jiang He · University Of Virginia · R01 · FY2018 · CA
A translational study of a synthetic lethality interaction of CD105 and androgen receptor signaling axis for castration-resistant prostate cancer patients
$575,242Neil A Bhowmick · Cedars-Sinai Medical Center · R01 · FY2025 · CA
Role of O-GlcNAcome on Breast Cancer Initiating Cells
$575,137Mauricio J. Reginato · Drexel University · U01 · FY2020 · CA
Metabolic Targets in Pten-Tumors
$575,122Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2013 · CA
PSMA-VRP vaccine for prostate cancer
$574,893William C Olson · Progenics Pharmaceuticals, Inc. · R44 · FY2008 · CA
Microtubule (MT) Interfering Agents (MTAs): Mechanisms of Action and Resistance
$574,878Antonio Fojo · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Chemical markers of heterocyclic aromatic amines for human biomonitoring
$574,804Robert J. Turesky · University Of Minnesota · R01 · FY2016 · CA
Discovery and qualification of transcriptomic biomarkers for the early detection of aggressive prostate cancer
$574,716Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2020 · CA
Human-like automated radiotherapy treatment planning via imitation learning
$574,629Steve Bin Jiang · Ut Southwestern Medical Center · R01 · FY2024 · CA
Outcomes of Prostate Cancer Androgen Deprivation Therapy
$574,599Arnold L Potosky · Georgetown University · R01 · FY2011 · CA
Phase II Clinical trial of GTC in Men on Active Surveillance
$574,580Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
TARGETING DISCOIDIN DOMAIN RECEPTORS IN PROSTATE CANCER
$574,375Wayne State University · · FY2015 · Department of the Army
VPAC1 Recpetor-Targeted PET Imaging of Prostate Cancer
$574,298Mathew L Thakur · Thomas Jefferson University · R01 · FY2012 · CA
Predicting Prostate Cancer Aggressiveness
$574,247Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2012 · CA
Targeting apoptotic cells to enhance radiotherapy
$574,207Jianghong Rao · Stanford University · R01 · FY2022 · CA
Screening for Free: A Value-Based Insurance Design Natural Experiment
$574,154John Hsu · Massachusetts General Hospital · R01 · FY2015 · CA
Medical Care Burden of Cancer: System and Data Issues
$574,102Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2009 · CA